The ATF7IP Knockout A-549 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population derived from A-549 human lung adenocarcinoma cells, designed for loss-of-function studies of the ATF7IP gene. The pool comprises cells with diverse gene-disrupting alleles generated by non-homologous end joining, avoiding biases of single-cell clones. This model facilitates investigation of ATF7IP-dependent processes in an endogenous setting.
The host A-549 cell line, established from a lung adenocarcinoma of a 58-year-old male, serves as a canonical model for human lung adenocarcinoma. These adherent epithelial cells exhibit type II alveolar cell features and are widely utilized in cancer biology, drug metabolism, and viral infection research, including studies on influenza and adenovirus. Their reproducible growth and amenability to genetic manipulation underpin their utility for CRISPR-mediated gene targeting.
ATF7IP functions as a key transcriptional corepressor that integrates DNA methylation and histone modification to establish heterochromatin. The protein binds to MBD1 at methylated DNA sites, thereby recruiting SETDB1 to catalyze H3K9me3, a repressive mark recognized by HP1 alpha. This ATF7IP?CSETDB1 complex is regulated by DNA methylation and the ATF7 transcription factor, and it silences target loci such as TERT and retroviral elements, linking ATF7IP to tumorigenesis and viral latency.
In the A-549 cellular context, ATF7IP knockout provides insights into epigenetic vulnerabilities in lung adenocarcinoma. Disruption of ATF7IP is anticipated to reduce H3K9me3 levels and alleviate transcriptional repression, potentially affecting cell proliferation and colony formation. Because ATF7IP is implicated in melanoma and acute myeloid leukemia, this model extends to pan-cancer epigenetic studies. Additionally, the permissiveness of A-549 cells to viral entry enables exploration of ATF7IP??s role in retroviral silencing and HIV latency maintenance.
Researchers can apply this knockout pool in a range of techniques, including Western blotting and immunofluorescence to monitor H3K9me3 changes, ChIP-qPCR to map ATF7IP and SETDB1 occupancy, and co-immunoprecipitation to assess complex integrity. Transcriptomic and DNA methylation profiling via RNA-seq and bisulfite sequencing reveals derepressed genes, while proliferation, colony formation, and viral reactivation assays measure functional consequences. For further details, contact Ascent Research.
